Skip to main content

Red Violet, Inc.

For the period ended Jun 30, 2026. Filed Aug 10, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 10, 2026

RDVT$70.10-2.8%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 15 previous paragraphs and 14 current paragraphs.

10 unchanged; 4 reworded; 0 added; 1 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

The current filing states there were no material changes to risk factors.

This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.

Current filing’s statement

There have been no material changes to the risk factors previously disclosed in the Company’s 2025 Form 10-K.
Removed paragraphs (1)

Previous report

From April 1, 2026 to April 30, 2026, the Company purchased an additional 9,750 shares at an average price of $37.74 per share pursuant to the Stock Repurchase Program.
Reworded paragraphs (4)

Previous wording

There have been no material changes to the risk factors previously disclosed in the Company’s Form 10-K.

Current wording

There have been no material changes to the risk factors previously disclosed in the Company’s 2025 Form 10-K.

Previous wording

On May 2, 2022, the Company's Board of Directors authorized the Stock Repurchase Program to repurchase the Company's common stock from time to time through open market purchases, privately negotiated transactions or other means, including pursuant to Rule 10b5-1 trading plans, which was subsequently amended on each of December 19, 2023, March 28, 2024, and November 3, 2025, bringing the total authorization to $30.0 million. The Stock Repurchase Program does not obligate the Company to repurchase any shares and may be modified, suspended, or terminated at any time at the discretion of the Board of Directors.

Current wording

On May 2, 2022, the Company's Board of Directors authorized the Stock Repurchase Program to repurchase the Company's common stock from time to time through open market purchases, privately negotiated transactions or other means, including pursuant to Rule 10b5-1 trading plans, which was subsequently amended on each of December 19, 2023, March 28, 2024, and November 3, 2025, bringing the total authorization to $30.0 million. The Stock Repurchase Program does not obligate the Company to repurchase any shares and may be modified, suspended, or terminated at any time at the discretion of the Company's Board of Directors.

Previous wording

During the three months ended March 31, 2026, 50,000 shares were repurchased through a Rule 10b5-1 plan, and the remaining were made in open-market transactions outside of any Rule 10b5-1 trading plan. Such repurchases were made in accordance with the limitations set forth in Rule 10b-18 and applicable securities laws.

Current wording

During the three months ended June 30, 2026, the Company repurchased 11,000 shares of its common stock under the Stock Repurchase Program, pursuant to a Rule 10b5-1 trading plan. Such repurchases were made in accordance with the limitations set forth in Rule 10b-18 and applicable securities laws.

Previous wording

Since the inception of the Stock Repurchase Program and through April 30, 2026, the Company has purchased a total of $14.4 million of common stock at an average price of $22.79 per share.

Current wording

Since the inception of the Stock Repurchase Program and through June 30, 2026, the Company has purchased a total of $14.5 million of common stock at an average price of $22.82 per share.